| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 61 | 妇女延更调理全营养配方食品 | CN201410402562.9 | 2014-08-16 | CN104256633A | 2015-01-07 | 胡安然 |
| 本发明提供了供更年期妇女食用的全营养配方食品、特定全营养配方食品或非全营养配方食品。该配方根据《特殊医学用途配方食品通则》的要求，结合更年期妇女的体质特征，综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果，依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则)研制而成。该产品采用多种药食两用的中药提取物精华、多种益生菌、短肽为主要原料，以益生元、碳水化合物、氨基酸、多种维生素及矿物质为辅料混合而成，不仅可作为单一营养来源满足更年期妇女的营养需求，还有起到活血祛瘀、调经止痛、开淤散结、养心、益阴、安神、镇潜及增强免疫力的功效。 | ||||||
| 62 | 子宫癌全营养配方食品 | CN201410575369.5 | 2014-10-25 | CN104256629A | 2015-01-07 | 胡安然 |
| 本发明提供了供子宫癌患者食用的全营养配方食品、特定全营养配方食品或非全营养配方食品。该配方根据《特殊医学用途配方食品通则》的要求，结合子宫癌患者的体质特征，采用多种经预水解SBE技术提取药食两用的中药提取物精华、多种微胶囊化的益生菌以及生物酶解提取的短肽、益生元、氨基酸、碳水化合物、多种维生素及矿物质一起粉碎混合而成，不仅可作为单一营养来源满足子宫癌患者的营养需求，还有起到平肝清热，益气健脾，固摄止血。活血行瘀，理气止痛、育阴滋肾及增强免疫力的功效。 | ||||||
| 63 | 一种肠道炎症性疾病防治的肠道微生态制剂 | CN201410134266.5 | 2014-04-04 | CN104222732A | 2014-12-24 | 胡安然 |
| 本发明属于药食同源类配方食品技术领域，具体是一种肠道炎症性疾病防治的微生态制剂。根据肠道炎的体质特征，利用中医体质平衡原理，合理配伍山药、芡实、米仁、鸡内金、石斛、白术、木香、白豆蔻、厚朴花等，将其浸泡后加入β-环状糊精，用预水解SBE技术提取并浓缩后，配以水苏糖、芡实、糊精100℃干燥并灭菌6小时，配以L-谷氨酰胺粉碎并混合后进行巴氏灭菌1小时，然后添加微胶囊化后益生菌、酵母混合的工艺制成固体饮料，也可制成胶囊、方便食品。本发明的优势在于能通过饮食调节恢复人体平衡，达到稳定健康状态，减小致肠道炎相关病症发展的效果。 | ||||||
| 64 | 促进非自然分娩后的肠屏障完整成熟的方法 | CN201310722592.3 | 2006-10-06 | CN103816173A | 2014-05-28 | 琼希姆·施密特; 巩特尔·勃姆; 克里斯托弗·比尔曼 |
| 本申请涉及促进非自然分娩后的肠屏障完整成熟的方法。本发明涉及喂养及促进剖腹产婴儿健康的方法，包括给予剖腹产婴儿长链多不饱和脂肪酸和/或核苷酸。 | ||||||
| 65 | 一种去除体内湿寒酵素及其制备方法 | CN201410083137.8 | 2014-03-10 | CN103798803A | 2014-05-21 | 王猛 |
| 本发明涉及一种去除体内湿寒酵素及其制备方法；其原料成分：葵花籽35%、胡萝卜25%、山药15%、秋葵10%、人参3%、生姜6%、大蒜6%；由益生菌群经三级发酵而成，该一种去除体内湿寒酵素的制备方法如下（A）将上述原料中的葵花籽经文火炒熟，将其他材料粉碎后一同放入发酵釜，（B）发酵流程：1)投入大毛霉、酿酒酵母、蜂蜜酵母、汉逊酵母变种进行初级发酵，发酵期间7天，2）投入醋酸杆菌进行二级发酵，发酵期间30天，C)投入双歧青春乳酸杆菌进行三级发酵，发酵期间180天，发酵完成后所得悬液即为去除体内湿寒酵素酵素；本发明具有促进体温上升，增强免疫力的效果，适合虚寒体质的人群使用。 | ||||||
| 66 | 一种低盐发酵芥菜及其制备方法 | CN201310696768.2 | 2013-12-18 | CN103719788A | 2014-04-16 | 张雁; 邓媛元; 李健雄; 刘磊; 遆慧慧; 陈于陇; 魏振承 |
| 本发明公开了一种低盐发酵芥菜，该低盐发酵芥菜中食盐含量低于5g/kg、亚硝酸盐含量低于4mg/kg。该低盐发酵芥菜食盐和亚硝酸盐含量低，有利于人体健康。还公开了上述低盐发酵芥菜的制备方法，含以下步骤：（1）制备发酵基础料液，先制备生姜和大蒜的水提取液，得天然香辛料提取液，在天然香辛料提取液中加入食盐、低聚异麦芽糖和低聚果糖，混匀得发酵基础料液；（2）选取芥菜，预处理后置于发酵容器中，加入发酵基础料液，并加入嗜热链球菌浓缩菌液和保加利亚乳杆菌浓缩菌液，然后密封发酵容器，室温下发酵；（3）发酵一天后，开启发酵容器，接种入青春双歧杆菌浓缩菌液后密封发酵容器，室温下继续发酵4~6天，即得到低盐发酵芥菜。 | ||||||
| 67 | 刺激肠内菌群的方法 | CN201310148476.5 | 2006-10-20 | CN103230005A | 2013-08-07 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a）至少两种不同的微生物；或b）至少一种微生物和至少一种不消化的寡糖；或c）至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 68 | 预防剖腹产分娩的婴儿疾病的方法 | CN201210414761.2 | 2006-10-06 | CN102919663A | 2013-02-13 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 69 | 预防剖腹产分娩的婴儿疾病的方法 | CN200680047651.X | 2006-10-06 | CN101330838A | 2008-12-24 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物的应用，这种组合物适用于肠道给予剖腹产婴儿。 | ||||||
| 70 | 刺激肠内菌群的方法 | CN200680035474.3 | 2006-10-20 | CN101272701A | 2008-09-24 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a)至少两种不同的微生物；或b)至少一种微生物和至少一种不消化的寡糖；或c)至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 71 | Prevention of a disease in infants which are birth by caesarean section | JP2008536530 | 2006-10-06 | JP2009512686A | 2009-03-26 | クノール、ヤン; シュミット、ヨアヒム; スタール、ベルント |
| 本発明は、帝王切開により出産された乳幼児に経腸的に投与するための組成物の製造のための、非消化性オリゴ糖を含む組成物の使用を提供する。
【選択図】 なし |
||||||
| 72 | Methods and Compositions for Improved Digestion of Milk Oligosaccharides | US14305868 | 2014-06-16 | US20150010670A1 | 2015-01-08 | David Mills; Daniel Garrido; Santiago Ruiz-Moyano; Carlito Lebrilla; J. Bruce German |
| Pre-biotic compositions containing oligosaccharides and probiotic compositions useful for treatment of a subject are provided herein. Also provided are methods for administering probiotic or pre-biotic compositions. | ||||||
| 73 | PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS | US13519493 | 2010-12-28 | US20120301435A1 | 2012-11-29 | Pirjo Wacklin; Jaana Matto; Harri Makivuokko |
| The present invention relates to a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. The present invention further relates to a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | ||||||
| 74 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | US12091047 | 2006-10-06 | US20090263537A1 | 2009-10-22 | Joachim Schmitt; Gunther Boehm |
| The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides | ||||||
| 75 | Method for stimulating the intestinal flora | US14973166 | 2015-12-17 | US09596876B2 | 2017-03-21 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 76 | Preventing diseases in infants delivered via caesarean section | US14813845 | 2015-07-30 | US09585416B2 | 2017-03-07 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 77 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US14813845 | 2015-07-30 | US20150335053A1 | 2015-11-26 | Joachim SCHMITT; Bernd STAHL; Jan KNOL |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 78 | Preventing diseases in infants delivered via caesarean section | US14135171 | 2013-12-19 | US09107438B2 | 2015-08-18 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 79 | Preventing diseases in infants delivered via caesarean section | US12091011 | 2006-10-06 | US08715769B2 | 2014-05-06 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 80 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US14135171 | 2013-12-19 | US20140105865A1 | 2014-04-17 | Joachim SCHMITT; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
QQ群二维码
意见反馈
意见反馈